a growth hormone-releasing factor analog, is FDA-approved for the treatment of HIV-associated lipodystrophy , with studies showing significant reduction in visceral adipose tissue (VAT) after 26 weeks of useSource: Falutz et al., New England Journal of Medicine, 2010
It contains no preservatives and is meant for single-use only
These unique properties make AOD9604 premixed pen an exciting focus for scientists exploring weight management, metabolic health, and tissue regeneration laboratory studies
Studies have shown an increased prevalence of this gene variant in patients with inflammatory bowel disease compared to the normal population
Rating 4.8 500+ reviews MIC+B12 $175 Transform your health and wellbeing Improve your physical health Shedding even 10% of your body weight can support heart health, increase energy levels, and promote better sleep
Heart and circulatory physiology (2014) Sosne G, Ousler GW Clinical ophthalmology (Auckland, N.Z.) (2015) Ruff D, et al